Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRAS and BRAF mutational status in colon cancer from Albanian patients.

Diagnostic pathology - 30 Sept 2014

Martinetti Daniela, Costanzo Rosario, Kadare Shahin, Alimehmeti Mehdiu, Colarossi Cristina, Canzonieri Vincenzo, Berretta Massimiliano, Memeo Lorenzo

Abstract excerpt

BACKGROUND: Numerous clinical studies have shown that anti-EGFR therapies are effective only in a subset of patients with colorectal cancer. Mutations in the KRAS and BRAF genes have been confirmed as negative predictors of the response to EGFR-targeted therapies.In this study we evaluated KRAS and BRAF status in 159 colorectal cancer samples obtained from the University of Tirana. METHODS: We evaluated KRAS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Colonic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to DNA Mutational Analysis

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Share to Sequence Analysis, DNA

Source

Open in PubMed Open full text

Identifiers

PMID: 25267307
DOI: 10.1186/s13000-014-0187-7
PMCID: PMC4198623

Genes

BRAF
KRAS
EGFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRAS and BRAF mutational status in colon cancer from Albanian patients.PMID 25267307Read ↗

Differences in anatomoclinical profiles between RAS-Mutated and Wild-Type colorectal cancers in an Eastern Algerian Cohort.Semantic proximity Read ↗

Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran.Semantic proximity Read ↗

Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients.Semantic proximity Read ↗

Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran.Semantic proximity Read ↗

Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients.Semantic proximity Read ↗

Targeting BRAF and RAS in Colorectal CancerSemantic proximity Read ↗

Prevalence and Patterns of Mutations in RAS/RAF/MEK/ERK/MAPK Signaling Pathway in Colorectal Cancer in North AfricaSemantic proximity Read ↗

Distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer.Semantic proximity Read ↗

Evaluation of KRAS Gene Mutations in Metastatic Colorectal Cancer Patients in Kermanshah Province.Semantic proximity Read ↗

Exploring the Relationship Between KRAS, NRAS, and BRAF Mutations and Clinical Characteristics in Iranian Colorectal Cancer Patients.Semantic proximity Read ↗

Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancerSemantic proximity Read ↗

KRAS and BRAF mutations in Nigerian colorectal cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.